Tomáš Mrkvan

2.1k total citations
32 papers, 1.7k citations indexed

About

Tomáš Mrkvan is a scholar working on Epidemiology, Biomaterials and Molecular Biology. According to data from OpenAlex, Tomáš Mrkvan has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Biomaterials and 7 papers in Molecular Biology. Recurrent topics in Tomáš Mrkvan's work include Nanoparticle-Based Drug Delivery (10 papers), Herpesvirus Infections and Treatments (7 papers) and Pneumonia and Respiratory Infections (5 papers). Tomáš Mrkvan is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), Herpesvirus Infections and Treatments (7 papers) and Pneumonia and Respiratory Infections (5 papers). Tomáš Mrkvan collaborates with scholars based in Czechia, Belgium and United States. Tomáš Mrkvan's co-authors include Blanka Řı́hová, Karel Ulbrich, Tomáš Etrych, Petr Chytil, Milada Šírová, Charles D. Surh, Jonathan Sprent, Stacey N. Walters, Kylie E. Webster and Rachel E. Kohler and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Tomáš Mrkvan

32 papers receiving 1.6k citations

Peers

Tomáš Mrkvan
Wilson S. Meng United States
Marek Kovář Czechia
Thomas Schluep United States
Leslie R. Coney United States
Conlin P. O’Neil Switzerland
Zhi Ding China
Boris V. Afanasyev Russia
Michael J. Heffernan United States
Mingnan Chen United States
Wilson S. Meng United States
Tomáš Mrkvan
Citations per year, relative to Tomáš Mrkvan Tomáš Mrkvan (= 1×) peers Wilson S. Meng

Countries citing papers authored by Tomáš Mrkvan

Since Specialization
Citations

This map shows the geographic impact of Tomáš Mrkvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Mrkvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Mrkvan more than expected).

Fields of papers citing papers by Tomáš Mrkvan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomáš Mrkvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Mrkvan. The network helps show where Tomáš Mrkvan may publish in the future.

Co-authorship network of co-authors of Tomáš Mrkvan

This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Mrkvan. A scholar is included among the top collaborators of Tomáš Mrkvan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Mrkvan. Tomáš Mrkvan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGirr, Ashleigh, Desmond Curran, Emmanuelle Espié, et al.. (2019). The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis. Vaccine. 37(22). 2896–2909. 35 indexed citations
2.
Mrkvan, Tomáš, Stephen I. Pelton, Javier Ruiz‐Guiñazú, Arto A. Palmu, & Dorota Borys. (2018). Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience. Expert Review of Vaccines. 17(9). 797–818. 16 indexed citations
3.
Lecrenier, Nicolas, Rómulo E. Colindres, Desmond Curran, et al.. (2018). Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention. Expert Review of Vaccines. 17(7). 619–634. 76 indexed citations
4.
McGirr, Ashleigh, Desmond Curran, Emmanuelle Espié, et al.. (2018). The Comparative Efficacy, Safety, And Reactogenicity, of Herpes Zoster Vaccines: A Network Meta-Analysis. Value in Health. 21. S149–S149. 1 indexed citations
5.
Curran, Desmond, Desirée Van Oorschot, Lijoy Varghese, et al.. (2017). Assessment of the potential public health impact of Herpes Zoster vaccination in Germany. Human Vaccines & Immunotherapeutics. 13(10). 2213–2221. 39 indexed citations
6.
Burnett, Heather, Ashleigh McGirr, Desmond Curran, et al.. (2017). Vaccines for Herpes Zoster: A Systematic Review of Randomized Controlled Trials In Adults ≥50 Years of Age. Value in Health. 20(9). A780–A780. 2 indexed citations
7.
McGirr, Ashleigh, Heather Burnett, Desmond Curran, et al.. (2017). Network Meta-Analysis In The Evaluation of Vaccines. Value in Health. 20(9). A777–A777. 1 indexed citations
8.
Giudice, Giuseppe Del, Jörg J. Goronzy, Beatrix Grubeck‐Loebenstein, et al.. (2017). Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging. SHILAP Revista de lepidopterología. 4(1). 1–1. 76 indexed citations
9.
10.
11.
Webster, Kylie E., Stacey N. Walters, Rachel E. Kohler, et al.. (2009). In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. The Journal of Experimental Medicine. 206(4). 751–760. 426 indexed citations
12.
Bouček, J, Tomáš Mrkvan, Martin Chovanec, et al.. (2009). Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck. Journal of Cellular and Molecular Medicine. 14(1-2). 426–433. 49 indexed citations
13.
Chytil, Petr, Tomáš Etrych, Čestmı́r Koňák, et al.. (2008). New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting. Journal of Controlled Release. 127(2). 121–130. 110 indexed citations
14.
Etrych, Tomáš, Tomáš Mrkvan, Blanka Řı́hová, & Karel Ulbrich. (2007). Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy. Journal of Controlled Release. 122(1). 31–38. 54 indexed citations
15.
Chytil, Petr, Tomáš Etrych, Čestmı́r Koňák, et al.. (2006). Properties of HPMA copolymer–doxorubicin conjugates with pH-controlled activation: Effect of polymer chain modification. Journal of Controlled Release. 115(1). 26–36. 78 indexed citations
16.
Šírová, Milada, J. Strohalm, Vladimír Šubr, et al.. (2006). Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice. Cancer Immunology Immunotherapy. 56(1). 35–47. 54 indexed citations
17.
Řı́hová, Blanka, J. Strohalm, Kateřina Kubáčková, et al.. (2005). Drug-HPMA-HuIg Conjugates Effective Against Human Solid Cancer. Kluwer Academic Publishers eBooks. 519. 125–143. 18 indexed citations
18.
Strohalm, J., Tomáš Mrkvan, Vladimír Šubr, et al.. (2005). Induction of Systemic Antitumour Resistance with Targeted Polymers. Scandinavian Journal of Immunology. 62(s1). 100–105. 21 indexed citations
19.
Kovář, Marek, Lubomír Kovář, Vladimír Šubr, et al.. (2004). HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: comparison of biological properties in vitro. Journal of Controlled Release. 99(2). 301–314. 38 indexed citations
20.
Kovář, Marek, Tomáš Mrkvan, J. Strohalm, et al.. (2003). HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemia. Journal of Controlled Release. 92(3). 315–330. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wilson S. Meng Breakdown of academic impact, for papers by Marek Kovář Breakdown of academic impact, for papers by Thomas Schluep Breakdown of academic impact, for papers by Leslie R. Coney Breakdown of academic impact, for papers by Conlin P. O’Neil Breakdown of academic impact, for papers by Zhi Ding Breakdown of academic impact, for papers by Boris V. Afanasyev Breakdown of academic impact, for papers by Michael J. Heffernan Breakdown of academic impact, for papers by Mingnan Chen
Rankless by CCL
2026